Dr. Jaenisch is an Infectious Disease Epidemiologist and Clinical Scientist. For the last 15 years, he has coordinated multicentric observational clinical research projects on arbovirus infections like Dengue or Zika.

His research was instrumental to provide key evidence for the WHO Dengue classification of 2009. After that, he focused on warning signs for severe Dengue and on standardized severe disease endpoints in Dengue. When the Zika epidemic hit Latin America in 2016, he was able to use the existing network of partners to mount a research response against Zika.

Dr. Jaenisch is involved in large multicentric pregnant women and children cohorts in Latin America as well as in Data Sharing and Harmonization of Infectious Disease cohorts, building on the ongoing Zika birth cohorts.

Dr Jaenisch was trained as a Medical Doctor in Germany, has obtained a PhD in International Health at Johns Hopkins University Bloomberg School of Public Health, and has worked in Tropical Medicine and Global Health at Heidelberg University Hospital from 2005-2019. He was recently recruited as the Director of the new Arbovirus Research Consortium (ARC), located at the Center for Global Health at the Colorado School of Public Health.

Dr. Jaenisch is an Infectious Disease Epidemiologist and Clinical Scientist. For the last 15 years, he has coordinated multicentric observational clinical research projects on arbovirus infections like Dengue or Zika.

His research was instrumental to provide key evidence for the WHO Dengue classification of 2009. After that, he focused on warning signs for severe Dengue and on standardized severe disease endpoints in Dengue. When the Zika epidemic hit Latin America in 2016, he was able to use the existing network of partners to mount a research response against Zika.

Dr. Jaenisch is involved in large multicentric pregnant women and children cohorts in Latin America as well as in Data Sharing and Harmonization of Infectious Disease cohorts, building on the ongoing Zika birth cohorts.

Dr Jaenisch was trained as a Medical Doctor in Germany, has obtained a PhD in International Health at Johns Hopkins University Bloomberg School of Public Health, and has worked in Tropical Medicine and Global Health at Heidelberg University Hospital from 2005-2019. He was recently recruited as the Director of the new Arbovirus Research Consortium (ARC), located at the Center for Global Health at the Colorado School of Public Health.

Dr. Jaenisch is an Infectious Disease Epidemiologist and Clinical Scientist. For the last 15 years, he has coordinated multicentric observational clinical research projects on arbovirus infections like Dengue or Zika.

His research was instrumental to provide key evidence for the WHO Dengue classification of 2009. After that, he focused on warning signs for severe Dengue and on standardized severe disease endpoints in Dengue. When the Zika epidemic hit Latin America in 2016, he was able to use the existing network of partners to mount a research response against Zika.

Dr. Jaenisch is involved in large multicentric pregnant women and children cohorts in Latin America as well as in Data Sharing and Harmonization of Infectious Disease cohorts, building on the ongoing Zika birth cohorts.

Dr Jaenisch was trained as a Medical Doctor in Germany, has obtained a PhD in International Health at Johns Hopkins University Bloomberg School of Public Health, and has worked in Tropical Medicine and Global Health at Heidelberg University Hospital from 2005-2019. He was recently recruited as the Director of the new Arbovirus Research Consortium (ARC), located at the Center for Global Health at the Colorado School of Public Health.

Dr. Jaenisch is an Infectious Disease Epidemiologist and Clinical Scientist. For the last 15 years, he has coordinated multicentric observational clinical research projects on arbovirus infections like Dengue or Zika.

His research was instrumental to provide key evidence for the WHO Dengue classification of 2009. After that, he focused on warning signs for severe Dengue and on standardized severe disease endpoints in Dengue. When the Zika epidemic hit Latin America in 2016, he was able to use the existing network of partners to mount a research response against Zika.

Dr. Jaenisch is involved in large multicentric pregnant women and children cohorts in Latin America as well as in Data Sharing and Harmonization of Infectious Disease cohorts, building on the ongoing Zika birth cohorts.

Dr Jaenisch was trained as a Medical Doctor in Germany, has obtained a PhD in International Health at Johns Hopkins University Bloomberg School of Public Health, and has worked in Tropical Medicine and Global Health at Heidelberg University Hospital from 2005-2019. He was recently recruited as the Director of the new Arbovirus Research Consortium (ARC), located at the Center for Global Health at the Colorado School of Public Health.